We are live on ! Find out more
MC

Moors & Cabot Portfolio holdings

AUM $2.34B
1-Year Est. Return 30.42%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+30.42%
3 Year Est. Return
+101.7%
5 Year Est. Return
+135.96%
10 Year Est. Return
+427.28%
AUM
$2.01B
AUM Growth
+$135M
Cap. Flow
+$8.42M
Cap. Flow %
0.42%
Top 10 Hldgs %
25.32%
Holding
920
New
62
Increased
363
Reduced
357
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 22.65%
2 Energy 11.56%
3 Financials 9.32%
4 Industrials 9.08%
5 Healthcare 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVUE icon
101
Kenvue
KVUE
$37B
$4.17M 0.21%
180,201
-3,280
-2% -$68K
IBB icon
102
iShares Biotechnology ETF
IBB
$9.31B
$4.16M 0.21%
28,582
-459
-2% -$66.4K
BMY icon
103
Bristol-Myers Squibb
BMY
$127B
$4.02M 0.2%
77,651
-7,454
-9% -$350K
QGEN icon
104
Qiagen
QGEN
$8.53B
$3.92M 0.19%
83,658
FISV
105
Fiserv Inc
FISV
$27.2B
$3.89M 0.19%
21,630
-320
-1% -$52.8K
CASY icon
106
Casey's General Stores
CASY
$31.9B
$3.86M 0.19%
10,282
-78
-0.8% -$29.2K
SYK icon
107
Stryker
SYK
$127B
$3.84M 0.19%
10,643
+40
+0.4% +$13.8K
NEM icon
108
Newmont
NEM
$98.2B
$3.66M 0.18%
68,503
-1,762
-3% -$87.5K
SHW icon
109
Sherwin-Williams
SHW
$78.3B
$3.66M 0.18%
9,580
+304
+3% +$106K
MRNA icon
110
Moderna
MRNA
$21.5B
$3.64M 0.18%
54,469
+8,390
+18% +$770K
GDX icon
111
VanEck Gold Miners ETF
GDX
$23B
$3.63M 0.18%
91,082
+5,409
+6% +$205K
ALL icon
112
Allstate
ALL
$66.9B
$3.6M 0.18%
18,951
+97
+0.5% +$17.2K
EW icon
113
Edwards Lifesciences
EW
$47.6B
$3.59M 0.18%
54,437
-75
-0.1% -$5.45K
GLD icon
114
SPDR Gold Trust
GLD
$131B
$3.58M 0.18%
14,350
-296
-2% -$67.8K
KMB icon
115
Kimberly-Clark
KMB
$36.4B
$3.53M 0.18%
24,814
-273
-1% -$38.7K
AMD icon
116
Advanced Micro Devices
AMD
$851B
$3.45M 0.17%
21,018
+2,062
+11% +$313K
CI icon
117
Cigna
CI
$76.6B
$3.43M 0.17%
9,915
-11
-0.1% -$3.79K
CB icon
118
Chubb
CB
$140B
$3.41M 0.17%
11,825
+845
+8% +$232K
VUG icon
119
Vanguard Growth ETF
VUG
$216B
$3.36M 0.17%
52,524
+8,280
+19% +$513K
NVS icon
120
Novartis
NVS
$295B
$3.28M 0.16%
28,559
-250
-0.9% -$28.4K
AME icon
121
Ametek
AME
$55.5B
$3.24M 0.16%
18,861
+539
+3% +$90K
AMAT icon
122
Applied Materials
AMAT
$426B
$3.21M 0.16%
15,897
-175
-1% -$35.9K
PARA
123
DELISTED
Paramount Global Class B
PARA
$3.2M 0.16%
301,571
-2,222
-0.7% -$24.2K
KMI icon
124
Kinder Morgan
KMI
$73.1B
$3.19M 0.16%
144,529
+468
+0.3% +$9.86K
APD icon
125
Air Products & Chemicals
APD
$66.3B
$3.18M 0.16%
10,688
-334
-3% -$91.3K

Similar funds

Moors & Cabot's Q3 2024 Portfolio in Review

As of Q3 2024, Moors & Cabot held 920 positions worth $2.01B, up 7.2% from $1.88B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Moors & Cabot's Q3 2024 filing shows 62 new, 363 increased, 357 reduced and 47 closed positions. Its largest new stake was LandBridge Co: 109,970 shares worth $4.3M. The largest sale was Texas Pacific Land, an estimated $2.88M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Energy and Financials.

  • Moors & Cabot's largest Q3 2024 buy was LandBridge Co: 109,970 shares worth $4.3M.
  • Moors & Cabot added most to Cintas in Q3 2024, an estimated $1.16M increase.
  • Moors & Cabot's biggest Q3 2024 reduction was Texas Pacific Land, cutting an estimated $2.88M.
  • Moors & Cabot fully exited Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q3 2024, selling an estimated $681K.
  • Moors & Cabot's ten largest holdings make up 25% of its $2.01B portfolio in Q3 2024.
  • Moors & Cabot opened 62 new positions and closed 47 in Q3 2024.
  • Moors & Cabot's portfolio value rose 7.2% quarter-over-quarter to $2.01B.

Based on Moors & Cabot's 13F filing for Q3 2024, filed 8 Nov 2024.